Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a/STAT3/IL-6R feedback loop, and modifies antitumor immunity

体内 癌症研究 医学 车站3 免疫系统 佐剂 CD8型 细胞毒性T细胞 药理学 体外 单克隆抗体 抗体 外周血单个核细胞 免疫学 生物 细胞凋亡 生物技术 生物化学
作者
Yicun Han,Xiuqi Fan,Liyan Fan,Yaosong Wu,Zhexu Zhou,Ge Wang,Lanwei Guo,Weiqi Gao,Yulong Chen,Qilong Gao
出处
期刊:Phytomedicine [Elsevier]
卷期号:111: 154672-154672 被引量:3
标识
DOI:10.1016/j.phymed.2023.154672
摘要

Liujunzi decoction (LJZD), a traditional herbal formula and one of the most commonly used adjuvant medications for the treatment of oesophageal squamous cell carcinoma (ESCC), exerts good antitumor and immunomodulatory activity. However, its specific mechanism of action remains largely unclear.In order to examine the potential primary and adjuvant antitumor mechanisms of LJZD, both in vitro and in vivo.IL-6 and miR-34a inhibitors were used to activate the miR-34a/STAT3/IL-6R feedback loop to observe the effects of LJZD. A humanised mouse model with a functional human immune system was constructed to evaluate the antitumor efficacy of LJZD in vivo on xenograft tumours, which was compared to that of the positive control drug anti-PD-1 monoclonal antibodies (mAb). Finally, a co-culture system of peripheral blood mononuclear and tumour cells in vitro was used to analyse the cytotoxic activity of LJZD on T cells.LJZD significantly interfered with IL-6-induced activation of the miR-34a/STAT3/IL-6R feedback loop in ESCC by restoring the expression of the tumour suppressor miR-34a, and inhibited the proliferation of EC109 oesophageal cancer cells in a dose-dependant manner. Furthermore, LJZD effectively suppressed oesophageal tumour growth in vivo and alleviated organ injury and visceral index. Furthermore, LJZD boosted antitumor immunity by increasing IFN-γ expression and CD8+tumour-infiltrating lymphocytes (TILs) infiltration in the peripheral blood and tumour tissues, respectively, which may be related to a decrease in PD-1, but not PD-L1 expression. Finally, we confirmed that LJZD strengthens the killing ability of T cells by suppressing PD-1 expression in a co-culture system in vitro.LJZD exerts excellent antitumor effect by interfering with the miR-34a/STAT3/IL-6R feedback loop and augmenting antitumor immune responses. Which provides new insights into mechanisms for LJZD and sheds light on the multifaceted role of phytomedicine in cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
食堂里的明湖鸭完成签到 ,获得积分10
6秒前
葫芦芦芦完成签到 ,获得积分10
10秒前
雪山飞龙发布了新的文献求助10
12秒前
蕉鲁诺蕉巴纳完成签到,获得积分10
14秒前
cheng发布了新的文献求助30
15秒前
16秒前
桐桐应助南栀采纳,获得10
16秒前
兴奋冷松完成签到,获得积分10
17秒前
顺利的曼寒完成签到 ,获得积分10
18秒前
cheng完成签到,获得积分10
25秒前
李新光完成签到 ,获得积分10
29秒前
29秒前
33秒前
22yh完成签到,获得积分10
34秒前
feng发布了新的文献求助10
39秒前
南栀发布了新的文献求助10
41秒前
薰硝壤应助科研通管家采纳,获得10
42秒前
InfoNinja应助科研通管家采纳,获得30
42秒前
ychao应助科研通管家采纳,获得10
42秒前
科研通AI2S应助科研通管家采纳,获得10
42秒前
ZJHYNL应助科研通管家采纳,获得10
43秒前
风中梦蕊完成签到 ,获得积分10
44秒前
刘洋完成签到 ,获得积分10
45秒前
blossoms完成签到 ,获得积分10
49秒前
yinshan完成签到 ,获得积分10
51秒前
lixinyue完成签到 ,获得积分10
53秒前
小鑫发布了新的文献求助10
56秒前
57秒前
GIPCY完成签到 ,获得积分10
1分钟前
毛毛完成签到,获得积分10
1分钟前
体贴的小翠完成签到,获得积分10
1分钟前
玄同发布了新的文献求助30
1分钟前
mm_zxh发布了新的文献求助10
1分钟前
小高同学完成签到,获得积分10
1分钟前
1分钟前
zjzjzjzjzj完成签到 ,获得积分10
1分钟前
柏林熊完成签到,获得积分10
1分钟前
老邱完成签到,获得积分10
1分钟前
Snow完成签到 ,获得积分10
1分钟前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
Introduction to Modern Controls, with illustrations in MATLAB and Python 310
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3056640
求助须知:如何正确求助?哪些是违规求助? 2713111
关于积分的说明 7434713
捐赠科研通 2358205
什么是DOI,文献DOI怎么找? 1249317
科研通“疑难数据库(出版商)”最低求助积分说明 607030
版权声明 596250